Notice ID: 4382def9c19c4bc33c12c07b84305ff5Combined Synopsis/Solicitation
66--Sole Source Antibodies
Archived on December 3, 2013. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 7:00 AM UTC+02:00
- Posted
- October 4, 2013
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
Notice details
- Place of performance
- US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD 21702-5014 US
- PSC
- 66: INSTRUMENTS AND LABORATORY EQPT
- Last updated
- Dec 3, 2025
Identifiers
- Solicitation number
- W81XWH13T0411
- Notice ID
- 4382def9c19c4bc33c12c07b84305ff5
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Institute of Surgical Research (USAISR) is soliciting a sole source acquisition for antibodies manufactured by Georg-August-Universitat Stiftung Offentlichen Rechts; Universitatsmedizin, Robert-Koch-Str. 42, 37099 Gottingen, Germany. Specifically, the Government will purchase the following antibodies: 4400 ug Z22/8 (anti-C3; 14,6 mg/ml) 1000 ug biotinylate K5/4 (anti-C3a; 0,58 mg/ml) 2200 ng hog C3a Standard (5 ug/ml) 2mg Z22/8 (anti-C3a) 2mg T13/9 (anti-C5a) The purchase of these specific antibodies is to study the role of the complement system in a trauma and the use of complement inhibitors to treat traumatic hemorrhage. These antibodies are the only available antibodies on the market that specially targets porcine complement components, C5a and C3a. Currently, no other vendor sells or distributes porcine specific antibodies for the complement components C5a and C3a. If you have any questions, please contact James Cheng at 301-619-1012 or electronically at james.cheng1.civ@mail.mil Please provide the following items when responding to this solicitation: -DUNS# -CAGE Code -TAX ID# (TIN) -Discount Terms (i.e. Net 30) -Delivery Time -Contact Information (Name, Telephone Number, Fax Number, and Email) -Any Shipping Cost
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
James Cheng, 301-619-1012 US Army Medical Research Acquisition Activity
Documents
No documents available.
Lifecycle
Solicitation:
W81XWH13T0411- Combined Synopsis
- Special NoticeSep 18, 2013
66--Notice of Intent to Sole Source for Antibodies
- Combined SynopsisCurrentOct 4, 2013
66--Sole Source Antibodies
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
W81XWH13T0411
Archive Date
Dec 3, 2013